Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...
Key challenges to developing "trans-tumor" targeted therapies are outlined in an editorial in the New England Journal of Medicine published Thursday by Fabrice André, head of the predictive biomarkers ...
BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, is ...
Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...
Next-generation sequencing (NGS) technologies have revolutionised phylogenetic analysis by enabling the acquisition of genome-scale data. Phylogenetic inference reconstructs evolutionary relationships ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...
A retrospective cohort study was conducted at Chris O'Brien Lifehouse, Sydney, including consecutive AYA patients with sarcoma who underwent tumor NGS between 2015 and 2025. Sequencing was performed ...
Now supporting both Illumina short-read and Oxford Nanopore long-read sequencing platforms, the NGD200 is the industry's first to enable WGS-based hospital transmission detection. CAMBRIDGE, MA / ACCE ...
If you are a bioinformatics platform lead, an ML infrastructure engineer, or a genomics budget owner who is now running ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results